Skip to main content
Tech Boon to Flu Forecasting
Drug Pricing Advisor to Depart
Charity Care Plunges
Industry Focus Reports
One Minute Matters Videos
Enter search term
Machine Learning, Wearable Devices Give Shot in the Arm to Flu Forecasting
HHS grants a research award to California-based company to develop and test a new model that could contribute to more...
Feds Pave The Way To Expand Home Dialysis — But Patients Hit Roadblocks
While home dialysis is convenient for patients, it can also be isolating, fraught with anxiety, technologically challenging and burdensome.
How Israel Does Healthcare Innovation; An Insider's Look for Americans
An Israeli innovation expert peels back the curtain for a look inside one of the world's leading health system innovation...
Get the latest on healthcare leadership in your inbox.
5 Innovation Strategies You Should Consider Now From a Global Perspective
How U.S. health systems measure up to a global innovation expert's recommendations.
Amazon Machine Learning Award to Accelerate and Scale UPMC-Affiliated Innovations
Consortium researchers will have access to Amazon's cloud-based platform and machine learning tools, providing early-stage innovation advantages.
Is IPPS Obsolete?
The inpatient prospective payment system provides for a new technology add-on payment, but it is vital for hospitals to understand...
Realizing the Promise of Technology at the Point of Care
Midmark is focused on developing innovative technology and new approaches that enrich experiences between caregivers and their patients at the...
Employers to Combat Rising Health Benefit Costs With Virtual Care Solutions
Nearly 40% of employers indicated that a more focused strategy on high cost claims was a top priority for 2020.
Allscripts Reaches $145M Settlement Over Subsidiary's HIPAA, Kickback Investigations
Practice Fusion, which is now known as Veradigm, had been under investigation for nearly a year when Allscripts acquired it...
Opinion: A community-guided genome editing project can fight Lyme disease
'Medicare-for-All' is a pipe dream, but here's why it matters for healthcare stocks
Two drugmakers closing in on opioid settlements
Top scientist categorically denies any wrongdoing in Novartis data manipulation scandal
Opinion: FDA should use its existing program to qualify new tools for drug safety testing
Many clinical trials for new cancer drugs didn't include any data on race